A Croydon dad who achieved fame as a bailiff on a TV show has been handed a "death sentence" unless a donor can be found to rescue him from terminal blood cancer.
Delroy Anglin is "Croydon born and bred" and found unexpected fame for his work as a bailiff on Channel 5's Can't Pay? We'll Take It Away!
Now the 56-year-old has been stricken by an aggressive form of leukaemia which ravages the blood and bones of its sufferers.
READ MORE: Charity seeking to save life of Croydon TV star tell well-wishers - 'you can save him'
The dad-of-six was confined to a hospital bed while undergoing punishing chemotherapy.
But the searing treatment can only battle the cancer for so long.
Delroy desperately needs a bone marrow transplant in order to beat the debilitating disease.
It is hard to find a matching donor because of his minority background, and he has suffered for months since first hearing the news of his illness.
"You feel as if someone has pronounced a death sentence," said Delroy, from Croydon Old Town.
READ MORE: This 8-year-old Croydon schoolboy is a musical genius despite being deaf
"Life changed in an instant. When they tell you, you're just hoping someone has made a mistake, but they haven't.
"At the end of the day, unless somebody says differently - I'm terminal."
His condition was first discovered after he requested a check-up because he had been catching more colds than he usually would.
A blood test revealed what was really affecting his usually robust health.
READ MORE: Missing People Choir on Britain's Got Talent: Who is missing Crystal Palace fan Lee Boxell?
AML affects the stem cells in bone marrow, causing a huge amount of white blood cells to be produced. Less than half of patients can be cured of the rare disease, which causes a dangerous reduction in the number of red blood cells in the body.
"I think I was in denial because I felt so fine," said Delroy, who has been forced to quit his on-screen work.
"Life changed straight away, from diagnosis to entering the hospital was a matter of days.
"Your life just changes instantly. Everything is chaotic and it remains like that for while."
Delroy, now a grandfather, is continuing to battle the disease, which developed with shocking speed, alongside his family.
His children have rallied to support him, and although his 82-year-old mum worries, her home cooking gives him strength.
"You don't want to worry your mum," said Delroy, who is now being treated at the Royal Marsden in Sutton.
"She does worry. She comes from a generation where leukaemia was a death sentence.
"But you get the home cooking from her and build up your strength it's funny how it never changes.
"You don't know how your kids are going to react. Some react well, some become aware of their own mortality a bit, and hate going to hospitals.
"But my family have reacted so well, and I think that's because they've seen my reaction. They've been absolutely amazing."
The expert bailiff, filmed alongside colleagues for the popular Channel 5 series, is facing the fight with calm determination.
His treatment has been gruelling, but he hopes there may be hope of victory over AML, although only a transplant will guarantee he beats the cancer which claimed his own brother's life 40 years ago.
He said: "For all intents and purposes I'm a pretty young bloke, you know, this is not supposed to happen. It just seems unreal.
"Chemotherapy is tough. The first time I had it I was in a wheelchair after. I looked in the mirror and didn't even recognise myself, I was so weak and frail.
"The next time I forced myself to take a few steps, and not let it do that to me again. Now I'm feeling positive about it. But it won't go away.
READ MORE: Former Crystal Palace striker talks with inspirational honesty about his battle with depression
"A transplant would be a game changer. It's the only way to get rid of it."
Transplanting fresh stem cells from donated bone marrow can treat the cancer.
But because Delroy is of African Caribbean origin his chances of finding a donor are slimmer because of the low number of donors with African Caribbean heritage on the donor register.
And none of Delroy's five siblings fit the criteria to make the vital donation.
His chances would be improved if more people from his background were on the register to donate bone marrow. Delroy thinks that the support he has received could translate into something positive for other sufferers.
"It's strange, people don't usually like bailiffs," he said.
"But I have had so much support, from everyone including complete strangers.
"I'm Croydon born and bred, I know everyone. And being on telly I still don't know how that happened that gives me an opportunity to raise awareness.
"Hopefully we can encourage more people to become donors, becasuse if I'm honest, even I didn't know anything about this issue."
A campaign has now begun to help find the missing match to save Delroy's life and more donors for future sufferers.
READ MORE: Emotional celebration held in memory of Croydon murder victim Bjorn Brown
The #Match4Delroy appeal is to be led by blood cancer charity the African Caribbean Leukaemia Trust (ACLT) and encourages people to join the donor register.
Delroy's daughter Domenique Anglin said: "He is a fantastic father to my siblings and a wonderful grandfather too.
"I am appealing on his behalf to all Caribbean and African people in the UK and abroad to join the register, in the hope they might be the match that saves his life."
Delroy's sister, Janet Hills, is chair of the Met Black Police Association.
She said: If you love Del on the show as much as I love him as my brother, then please, please, please make that commitment today to join the stem cells register."
To join the Stem Cell Register visit aclt.org
The rest is here:
Croydon dad who stars in Channel 5 show needs transplant to live after 'death sentence' diagnosis - Croydon Advertiser
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021